TC BIOPHARM (HOLDINGS) PLC
Maxim 1, 2 Parklands Way
Holytown, Motherwell ML1 4WR
Scotland, United Kingdom
May 26, 2022
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
Attention: Ms. Christine Westbrook
|Re:||TC BioPharm (Holdings) plc|
|Registration Statement on Form F-1, File No. 333-265159|
Ladies and Gentlemen:
Reference is made to the acceleration request letter of TC Biopharm (Holdings) plc (the “Company”) dated May 23, 2022 (the “Acceleration Request”) requesting, pursuant to Rule 461 under the Securities Act of 1933, as amended, the Securities and Exchange Commission (the “Commission”) to accelerate the effective date of the above-referenced Registration Statement and declare the Registration Statement, as then amended, effective as of 5:00 p.m., Eastern Daylight Time, on Wednesday, May 25, 2022, or as soon thereafter as practicable.
The Company hereby notifies the Commission of its withdrawal of the Acceleration Request for the above-referenced time until such time as the Company may subsequently request.
|By:||/s/ Martin Thorp|
|Chief Financial Officer|